Use of high-dose acyclovir in pityriasis rosea

Journal of the American Academy of Dermatology

Volumn 54, Issue 1, 2006, Pages 82-85

  Drago, Francesco ^a,b   Vecchio, Federica ^a   Rebora, Alfredo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Clinica Dermatologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PITYRIASIS ROSEA; PRIORITY JOURNAL; REMISSION; SKIN DEFECT; STATISTICAL SIGNIFICANCE;

ACYCLOVIR; ADMINISTRATION, ORAL; ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOGLOBULIN G; MALE; PITYRIASIS ROSEA; TIME FACTORS; TREATMENT OUTCOME;

EID: 29244435322     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.06.042     Document Type: Article

References (9)

1. F. Drago, E. Ranieri, F. Malaguti, E. Losi, and A. Rebora Human herpesvirus 7 and pityriasis rosea Lancet 349 1997 1367 1368
2. T. Watanabe, T. Kawamura, S.E. Jacob, E.A. Aquilino, J.M. Orenstein, and J.B. Black Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6 J Invest Dermatol 119 2002 793 797
3. F. Broccolo, F. Drago, A.M. Careddu, C. Foglieni, L. Turbino, and C.E. Cocuzza Additional evidence that pityriasis rosea is associated with reactivation of HHV-6 and HHV-7 J Invest Dermatol 124 2005 1234 1240
4. W.H. Burns, and G.R. Sandford Susceptibility of human herpesvirus-6 to antivirals in vitro J Infect Dis 162 1990 634 637
5. M. Yoshida, M. Yamada, T. Tsukazaki, S. Chatterjee, F.D. Lakeman, and S. Nii Comparison of antiviral compounds against human herpesvirus 6 and 7 Antiviral Res 40 1998 73 84
6. T. De Araujo, B. Berman, and A. Weinstein Human herpesviruses 6 and 7 Dermatol Clin 20 2002 301 306
7. F. Drago, and A. Rebora The new herpesviruses: emerging pathogens of dermatological interest Arch Dermatol 135 1999 71 75
8. J.P. Castanedo-Cazares, V. Lepe, and B. Moncada Should we still use phototherapy for Pityriasis rosea? Photodermatol Photoimmunol Photomed 19 2003 160 161
9. P.K. Sharma, T.P. Yadav, R.K. Gautam, N. Taneja, and L. Satyanarayana Erythromycin in pityriasis rosea: a double-blind, placebo-controlled clinical trial J Am Acad Dermatol 42 2000 241 244